Upcoming Projects (AGEN)
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (AGEN)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AGEN)
Agenus (AGEN) Doses First Patient in Phase 1/2 Study Evaluating AGEN2034 in Advanced Tumors and Cervical Cancer
Occurred on: Apr 20, 2017
Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-GITR Checkpoint Antibody INCAGN1876 in Patients with Solid Tumors
Occurred on: Jun 22, 2016
Strategic Initiatives (AGEN)
Incyte (INCY) and Agenus (AGEN) Announce Amended Collaboration Agreement
Tickers: AGEN, INCY
Announcement Date: Feb 14, 2017
Agenus Announces Lead Product Candidate Selection in its Collaboration with Merck
Tickers: AGEN, MRK
Announcement Date: Jun 09, 2016